iDayo Selects VVUS as Low Risk Investment

Call Now
800-993-0005

(^DJI) 0

0S&P 500 (^GSPC) 1321.61

0.93NASDAQ Composite (^IXIC) 2835.89

-3.49Russell 2000 (^RUT) 765.04

-1.53

iDayo™ Stock Selector: VVUS - Vivus Inc

iDayo™ 06/03/02: Vivus Inc (VVUS) - 06/03/02

For the 16 week investment period starting 06/03/02 , the iDayo™ Stock Selector rated Vivus Inc (VVUS) as "Heavy Accumulation" and selected VVUS as a buy for the investment period, identified as iDayo™ 06/03/02.

Company Profile for "Vivus Inc (VVUS)": VIVUS, Inc. focuses on the design and development of products for the treatment of erectile dysfunction whose products include MUSE (alprostadil) and ACTIS.

Google Finance History for VVUS

iDayo, Inc. (including its marketing professionals and staff), is not a registered Investment Advisor or Broker/Dealer, and does not provide investment advice or recommendations. Subscribers to iDayo™ are advised that the information, opinions, and analysis included in our web sites, on our free Educational Conference Calls, or in any other communication are based in good faith on sources believed to be reliable, but no representation or warranty, expressed or implied, is made as to their accuracy, completeness, or correctness.

Past performance is not necessarily indicative of the future performance of stocks posted. None of these postings, the iDayo™ system rating, nor any other information provided on our web sites, on our free Educational Conference Calls, or in any other communication constitutes a recommendation to buy or sell stocks or any other investment. Investing involves the risk of loss and Subscribers are urged to consult with their own independent financial advisors with respect to any investment.